Spatial distribution of nociceptive neuropeptide and nerve growth factor depletion in experimental diabetic peripheral nervous system

Journal of International Medical Research

Volumn 30, Issue 5, 2002, Pages 512-519

  Kanbayashi, H ^a   Itoh, H ^a   Kashiwaya, T ^a   Atoh, K ^a   Makino, I ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Diabetes; Dorsal root ganglia; Nerve growth factor; Rats; Substance P

Indexed keywords

NERVE GROWTH FACTOR; NEUROPEPTIDE; SUBSTANCE P; GLYCOSYLATED HEMOGLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE DURATION; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; NERVE FIBER; NOCICEPTION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; RADIOIMMUNOASSAY; RAT; SENSORY NERVE CELL; SPINAL GANGLION; STREPTOZOCIN DIABETES; TIME; ANIMAL; BACK; BLOOD; DIABETIC NEUROPATHY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; METABOLISM; NECK; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; GANGLIA, SPINAL; HEMOGLOBIN A, GLYCOSYLATED; LUMBOSACRAL REGION; MALE; NECK; NERVE GROWTH FACTOR; RATS; RATS, WISTAR; SUBSTANCE P;

EID: 0036754791     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000203000507     Document Type: Article

References (39)

1. Thomas PK, Tomlinson DR: Diabetic and hypoglycaemic neuropathy. In: Peripheral Neuropathy (Dyck PJ, Thomas PK, eds). Philadephia: WB Saunders Co., 1993; pp1219-1250.
2. Greene DA, Lattimer SA, Sima AF: Sorbitol, phosphoinositides, and sodium potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 1987; 316: 599-606.
3. Dyck PJ, Lais A, Karnes JL, O’Brien P, Rizza R: Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann Neurol 1986; 19: 425-439.
4. Dyck PJ: Hypoxic neuropathy: does hypoxia play a role in diabetic neuropathy? Neurology 1989; 39: 111-118.
5. Malik RA: The pathology of human diabetic neuropathy. Diabetes 1997; 46 (Suppl 2): S50-S53.
6. Low PA, Tuck RR, Takeuchi M: Nerve microenvironment in diabetic neuropathy. In: Diabetic Neuropathy (Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte DH, Jr, eds). Philadelphia: WB Saunders Co., 1987; pp266-278.
7. Lawson SN, Perry MJ, Prabhakar E, McCarthy PW: Primary sensory neurones: neurofilament, neuropeptides, and conduction velocity. Brain Res Bull 1993; 30: 239-243.
8. Lawson SN: Neuropeptides in morphologically and functionally identified primary afferent neurons in DRGs: substance P, CGRP and somatostatin. Prog Brain Res 1995; 104: 161-173.
9. Smeyne RJ, Klein R, Schnapp A, Long LK, Bryant S, Lewin A, et al: Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature 1994; 368: 246-249.
10. Barbacid M: The Trk family neurotrophin receptors. J Neurobiol 1994; 25: 1386-1403.
11. Chao MV, Hempstead BL: p75 and Trk: a two-receptor systems. Trends Neuroscience 1995; 18: 321-326.
12. Hendry LA, Stoeckel K, Thoenen H, Iversen LL: The retrograde axonal transport of nerve growth factor. Brain Res 1974; 68: 103-121.
13. Meakin SO, Shooter EM: The nerve growth factor family of receptors. Trends Neurosci 1992; 15: 323-331.
14. 125I-nerver growth factor and effect of chemical sympathectomy. Diabetes 1985; 34: 1222-1229.
15. Goedert M, Stoeckel K, Otten U: Biological importance of the retrograde axonal transport of nerve growth factor in sensory neurons. Proc Natl Acad U S A 1981; 78: 5895-5898.
16. Lindsay RM, Harmar AJ: Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 1989; 337: 362-368.
17. Lindsay RM, Lockett C, Sternberg J, Winter J: Neuropeptide expression in cultures of adult sensory neurons: modulation of substance P and calcitonin gene-related peptide levels by nerve growth factor. Neuroscience 1989; 33: 53-65.
18. Anand P, Terenghi G, Warner G, Kopelman P, Williams-Chestnut RE, Sinicropi DV: The role of endogenous nerve growth factor in human diabetic neuropathy. Nat Med 1996; 2: 703-707.
19. Fernyhough P, Diemel LT, Brewster WJ, Tomlinson DR: Deficits in sciatic nerve neuropeptide content coincide with a reduction in target tissue nerve growth factor messenger RNA in streptozotocin-diabetic rats: effects of insulin treatment. Neuroscience 1994; 62: 337-344.
20. Fernyhough P, Diemel LT, Hardy J, Brewster WJ, Mohiuddin L, Tomlinson DR: Human recombinant nerve growth factor replaces deficient neurotrophic support in the diabetic rat. Eur J Neurosci 1995; 7: 1107-1110.
21. Schmidt RE, Modert CW, Yip HK, Johnson EM, Jr: Retrograde axonal transport of inttravenously administered 1251-nerve growth factor in rats with streptozotocin-induced diabetes. Diabetes 1983; 32: 654-663.
22. Schmidt RE, Plurad SB, Saffitz JE, Grabau GG, Yip HK: Retrograde transport of 125I-nerve growth factor in rat ileal mesenteric nerves. Effect of streptozotocin diabetes. Diabetes 1985; 34: 1230-1240.
23. 125I]nerve growth factor in ileal mesenteric nerves in vitro: effect of streptozotocin diabetes. Brain Res 1986; 378: 325-336.
24. Diemel LT, Brewster WJ, Fernyhough P, Tomlinson DR: Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain-derived neurotrophic factor. Mol Brain Res 1994; 21: 171-175.
25. Cooper GR: Methods for determining the amount of glucose in blood. CRC Crit Rev Clin Lab Sci 1973; 4: 101-145.
26. Inagaki S, Kito S: Peptides in the peripheral nervous systems. Prog Brain Res 1986; 66: 269-316.
27. Diemel LT, Stevens EJ, Willars GB, Tomlinson DR: Depletion of substance P and calcitonin gene-related peptide in sciatic nerve of rats with experimental diabetes; effects fo insulin and aldose reductase inhibition. Neurosci Lett 1992; 137: 253-256.
28. Robinson JP, Willars GB, Tomlinson DR, Keen P: Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductace inhibitor ‘statil’. Brain Res 1987; 426: 339-348.
29. Tomlinson DR, Robinson JP, Willars GB, Keen P: Deficient axonal transport of substance P in streptozotocin-induced diabetic rats. Effect of sorbinil and insulin. Diabetes 1988; 37: 488-493.
30. Apfel SC, Arezzo JC, Brownlee M, Federoff H, Kessler JA: Nerve growth factor administration protect againts experimental diabetic sensory neuropathy. Brain Res 1994; 634: 7-12.
31. Barinaga M: NGF signals ride a trolley to nucleus. Nature 1997; 227: 1037.
32. DiStefano PS, Friedman B, Radziejewki C, Alexander C, Boland P, Schick CM, et al: The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron 1992; 8: 983-993.
33. Johanson SO, Crouch MF, Hendry IA: Retrograde axonal transport of signal transduction protein in rat sciatic nerve. Brain Res 1995; 690: 55-63.
34. Klinz FJ, Heumann R: Time-resolved signaling pathways of nerve growth factor diverge downstream of the p140trk receptor activation between chick sympathetic and dorsal root ganglion sensory neurons. J Neurochem 1995; 65: 1046-1053.
35. Reynolds AJ, Bartlett SE, Hendry IA: Signalling events regulating the retrograde axonal transport of 125I-β nerve growth factor in vivo. Brain Res 1998; 798: 67-74.
36. Sango K, Verdes JM, Hikawa N, Horie H, Tanaka S: Nerve growth factor (NGF) restores depletions of calcitonin gene-related peptide and substance P in sensory neurons from diabetic mice in vitro. J Neurol Sci 1994; 126: 1-5.
37. Kasayama S, Oka T: Impaired production of nerve growth factor in the submandibular gland of diabetic mice. Am J Physiol 1989; 257: E400-E404.
38. Hellweg R, Raivich G, Hartung HD, Hock C, Kreutzberg GW: Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy. Exp Neurol 1994; 130: 24-30.
39. Jakobsen J, Brimijoin S, Skau K, Sidenius P, Wells D: Retrograde axonal transport of transmitter enzymes, fucose-labeled protein, and nerve growth factor in streptozotocin-diabetic rats. Diabetes 1981; 30: 797-803.